Commentary: Induction immunotherapy for esophageal cancer: A safe start
J Thorac Cardiovasc Surg
.
2021 Mar;161(3):844.
doi: 10.1016/j.jtcvs.2020.12.027.
Epub 2021 Jan 13.
Author
Mark Onaitis
1
Affiliation
1
Division of Cardiothoracic Surgery, University of California, San Diego, San Diego, Calif. Electronic address: monaitis@ucsd.edu.
PMID:
33454096
DOI:
10.1016/j.jtcvs.2020.12.027
No abstract available
Publication types
Editorial
Comment
MeSH terms
Chemoradiotherapy
Esophageal Neoplasms* / therapy
Esophagectomy*
Feasibility Studies
Humans
Immunotherapy / adverse effects